<SEC-DOCUMENT>0001071739-18-000124.txt : 20181213
<SEC-HEADER>0001071739-18-000124.hdr.sgml : 20181213
<ACCEPTANCE-DATETIME>20181213163033
ACCESSION NUMBER:		0001071739-18-000124
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181213
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181213
DATE AS OF CHANGE:		20181213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CENTENE CORP
		CENTRAL INDEX KEY:			0001071739
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				041406317
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31826
		FILM NUMBER:		181233552

	BUSINESS ADDRESS:	
		STREET 1:		7700 FORSYTH BLVD.
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63105
		BUSINESS PHONE:		3147254477

	MAIL ADDRESS:	
		STREET 1:		7700 FORSYTH BLVD.
		CITY:			ST LOUIS
		STATE:			MO
		ZIP:			63105
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sF5051F83E442AC234BD185A320899253"></a></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;"><hr></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">UNITED STATES </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">WASHINGTON, D.C. 20549 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">CURRENT REPORT </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of earliest event reported): December&#160;13, 2018</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">CENTENE CORPORATION </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact Name of Registrant as Specified in Charter) </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.4296875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:33%;"></td><td style="width:1%;"></td><td style="width:33%;"></td><td style="width:1%;"></td><td style="width:32%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">001-31826</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42-1406317</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;vertical-align:top;">(State or Other Jurisdiction </font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;vertical-align:top;">of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;vertical-align:top;">(IRS Employer </font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;vertical-align:top;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;vertical-align:top;">Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:65.625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:48%;"></td><td style="width:5%;"></td><td style="width:47%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7700 Forsyth Blvd. </font></div><div style="padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">St. Louis, Missouri</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63105</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Registrant&#8217;s telephone number, including area code: (314) 725-4477 </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Former Name or Former Address, if Changed Since Last Report) </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">x</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company&#160;</font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;"><hr></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 7.01 REGULATION FD DISCLOSURE</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">December&#160;13, 2018</font><font style="font-family:inherit;font-size:10pt;">, Centene Corporation (the "Company" or "Centene") the Company issued a press release announcing its </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;financial guidance and confirming its </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;financial guidance. The full text of the press release is included as Exhibit 99.1 to this report. </font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:10pt;">The Company will host an investor meeting tomorrow, including a question-and-answer session, to discuss the details of its guidance at the Pierre Hotel in New York City.  The meeting will begin promptly at 8:30 AM (Eastern Time) and end at approximately 1:15 PM (Eastern Time). Investors and other interested parties who are unable to attend in person are invited to listen to the investor meeting via a live, audio webcast on the Company</font><font style="font-family:inherit;font-size:11pt;">&#8217;</font><font style="font-family:inherit;font-size:10pt;">s website and view a copy of the investor presentation at </font><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">www.centene.com</font><font style="font-family:inherit;font-size:10pt;">, under the Investors section.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the website is not a part of this report.</font></div><div style="line-height:120%;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 8.01 OTHER EVENTS</font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 12, 2018, the Board of Directors declared a two-for-one split of the Centene's common stock in the form of a 100% stock dividend and is expected to be effective in the first quarter of 2019. The split is subject to stockholder approval of an amendment to Centene's certificate of incorporation to increase the number of authorized shares of common stock.</font></div><div style="line-height:120%;padding-top:0px;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Important Additional  Information and Where to Find It </font></div><div style="line-height:120%;padding-top:0px;text-align:justify;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Centene Corporation, its directors and its officers may be deemed to be participants in the solicitation of proxies from stockholders in connection with the special meeting seeking approval to increase the number of Centene&#8217;s authorized shares of common stock under its Certificate of Incorporation in order to effect a stock split (the &#8220;Special Meeting&#8221;). Centene plans to file a proxy statement with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) in connection with the solicitation of proxies for the Special Meeting (the &#8220;Proxy Statement&#8221;), together with a proxy card.  STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT CENTENE WILL FILE WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Additional information regarding the identity of these potential participants and their direct or indirect interests, by security holdings or otherwise, will be set forth in the Proxy Statement and other materials to be filed with the SEC in connection with the Special Meeting. Information relating to the foregoing can also be found in Centene&#8217;s definitive proxy statement for its 2018 Annual Meeting of Stockholders (the &#8220;2018 Proxy Statement&#8221;), filed with the SEC on March 9, 2018. To the extent holdings of Centene&#8217;s securities by such potential participants (or the identity of such participants) have changed since the information printed in the 2018 Proxy Statement, such information has been or will be reflected on Statements of Change in Ownership on Forms 3 and 4 filed with the SEC.</font></div><div style="line-height:120%;padding-top:15px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders will be able to obtain, free of charge, copies of the Proxy Statement, any amendments or supplements thereto and any other documents (including the proxy card) when filed by Centene with the SEC in connection with the Special Meeting at the SEC&#8217;s website (http://www.sec.gov), at the Centene&#8217;s website (https://investors.centene.com/financial-information/sec-filings) or by contacting our Secretary, Keith H. Williamson, by phone at 314-725-4477, by email at kwilliamson@centene.com or by mail at Centene Corporation, Attn: Keith H. Williamson, Centene Plaza, 7700 Forsyth Boulevard, St. Louis, Missouri 63105. In addition, copies of the proxy materials, when available, may be requested from the Company&#8217;s proxy solicitor, Saratoga Proxy Consulting, LLC at 212-257-1311 or toll-free at 888-368-0379.</font></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS </font></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d) Exhibits. </font></div><div style="line-height:120%;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1 </font><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit99120181213.htm"><font style="font-family:inherit;font-size:10pt;">Press release of Centene Corporation issued December&#160;13, 2018</font></a><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s10F82220733D83DFD57A85A320A98BD7"></a></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;&#32;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:671px;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:37px;"></td><td style="width:272px;"></td><td style="width:32px;"></td><td style="width:5px;"></td><td style="width:325px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CENTENE CORPORATION</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 13, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/ Jeffrey A. Schwaneke</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeffrey A. Schwaneke </font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Executive Vice President &amp; Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99120181213.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s94AA6670681DFC77C11F85A31FE7FA4E"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 99.1</font></div><div style="line-height:120%;text-align:right;"><img src="logo1a07.gif" alt="logo1a07.gif" style="height:60px;width:246px;"></div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">N E W S  R E L E A S E&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:68.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:13%;"></td><td style="width:87%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contact:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investor Relations Inquiries</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Edmund E. Kroll, Jr.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President, Finance &amp; Investor Relations</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(212) 759-0382</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Media Inquiries</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marcela Manjarrez-Hawn</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Vice President and Chief Communications Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(314) 445-0790</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">FOR IMMEDIATE RELEASE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CENTENE CORPORATION ANNOUNCES </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2019</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;GUIDANCE</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">-- CONFIRMS </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;GUIDANCE --</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">-- ANNOUNCES TWO-FOR-ONE STOCK SPLIT --</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ST. LOUIS, MISSOURI (</font><font style="font-family:inherit;font-size:10pt;">December&#160;13, 2018</font><font style="font-family:inherit;font-size:10pt;">) - Centene Corporation (NYSE: CNC) announced today its </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;financial guidance. Total revenues are expected to be </font><font style="font-family:inherit;font-size:10pt;">$69.7 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$70.5 billion</font><font style="font-family:inherit;font-size:10pt;">, representing growth of approximately </font><font style="font-family:inherit;font-size:10pt;">17%</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the midpoint of the </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;guidance range. Diluted earnings per share for 2019 are expected to be </font><font style="font-family:inherit;font-size:10pt;">$7.23</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$7.59</font><font style="font-family:inherit;font-size:10pt;">&#32;(pre-split). Adjusted diluted earnings per share for 2019 are expected to be </font><font style="font-family:inherit;font-size:10pt;">$8.15</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$8.55</font><font style="font-family:inherit;font-size:10pt;">&#32;(pre-split), representing an increase of </font><font style="font-family:inherit;font-size:10pt;">19%</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to the midpoint of the </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;guidance range.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 12, 2018, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend that is expected to be effective in the first quarter of 2019. The split is subject to stockholder approval of an amendment to Centene's certificate of incorporation to increase the number of authorized shares of common stock.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For its </font><font style="font-family:inherit;font-size:10pt;">2019</font><font style="font-family:inherit;font-size:10pt;">&#32;fiscal year, the Company expects the following: </font></div><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues in the range of </font><font style="font-family:inherit;font-size:10pt;">$69.7 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$70.5 billion</font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health benefits ratio of approximately </font><font style="font-family:inherit;font-size:10pt;">86.6%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">87.1%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling, general and administrative (SG&amp;A) and Adjusted SG&amp;A expense ratio of approximately </font><font style="font-family:inherit;font-size:10pt;">9.2%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">9.7%</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Effective tax rate of approximately </font><font style="font-family:inherit;font-size:10pt;">24.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">26.5%</font><font style="font-family:inherit;font-size:10pt;">. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted shares outstanding of approximately </font><font style="font-family:inherit;font-size:10pt;">210.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">211.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">420.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">422.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;post-split).</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per share of approximately </font><font style="font-family:inherit;font-size:10pt;">$7.23</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$7.59</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$3.62</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$3.80</font><font style="font-family:inherit;font-size:10pt;">&#32;post-split).</font></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted diluted earnings per share of approximately </font><font style="font-family:inherit;font-size:10pt;">$8.15</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$8.55</font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;">$4.08</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$4.28</font><font style="font-family:inherit;font-size:10pt;">&#32;post-split).</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company affirms its </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;revenue guidance in the previously announced range for total revenues of </font><font style="font-family:inherit;font-size:10pt;">$59.8 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$60.3 billion</font><font style="font-family:inherit;font-size:10pt;">, diluted earnings per share of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.34</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$4.50</font><font style="font-family:inherit;font-size:10pt;">&#32;(pre-split), and adjusted diluted earnings per share of approximately </font><font style="font-family:inherit;font-size:10pt;">$6.90</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">$7.10</font><font style="font-family:inherit;font-size:10pt;">&#32;(pre-split). Full year </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;earnings will be reported on </font><font style="font-family:inherit;font-size:10pt;">February&#160;5, 2019</font><font style="font-family:inherit;font-size:10pt;">, at 6:00 AM, with a conference call at 8:30 AM (Eastern Time). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Meeting</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Centene Corporation will host an investor meeting tomorrow at the Pierre Hotel in New York City, including a question-and-answer session, to discuss the details of its guidance. The meeting will begin promptly at 8:30 AM (Eastern Time) and end at approximately 1:15 PM (Eastern Time). Investors and other interested parties who are unable to attend in person are invited to listen to the investor meeting via a live, audio webcast on the Company's website and view a copy of the investor presentation at </font><font style="font-family:inherit;font-size:10pt;color:#0000ff;text-decoration:underline;">www.centene.com</font><font style="font-family:inherit;font-size:10pt;">, under the Investors section.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Non-GAAP Financial Presentation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is providing certain non-GAAP financial measures in this release as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. The Company references Adjusted SG&amp;A Expense Ratio, however the Company cannot provide a reconciliation of Adjusted SG&amp;A Expense Ratio guidance without unreasonable efforts.  As such, it has been excluded from the reconciliation below.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets, acquisition related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's performance over time. The table below provides reconciliations of non-GAAP items per share:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:566px;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:274px;"></td><td style="width:93px;"></td><td style="width:5px;"></td><td style="width:93px;"></td><td style="width:6px;"></td><td style="width:93px;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pre-Split</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pre-Split</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Post-Split</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(4)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Guidance December 31, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Guidance December 31, 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Annual Guidance December 31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GAAP diluted EPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.34 - $4.50</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$7.23 - $7.59</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$3.62 - $3.80</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of acquired intangible assets </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.81 - $0.83</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.90 - $0.92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.45 - $0.46</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition related expenses </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1.63 - $1.65</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.02 - $0.04</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.01 - $0.02</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;">California minimum MLR change </font><font style="font-family:inherit;font-size:10pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:7pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Adjusted diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$6.90 - $7.10</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$8.15 - $8.55</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$4.08 - $4.28</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The amortization of acquired intangible assets per diluted share presented above are net of the income tax benefit of an estimated $0.24 to $0.25 pre-split for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and an estimated and $0.30 to $0.31 pre-split and approximately $0.15 post-split for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The acquisition related expenses per diluted share presented above are net of the income tax benefit of an estimated $0.50 to $0.51 pre-split for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;and approximately $0.01 pre-split and approximately $0.00 post-split for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2019</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(3) </font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The California minimum MLR change per diluted share presented above is net of the income tax benefit of an estimated $0.03 pre-split for the year ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2018</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gives effect to the proposed two-for-one stock split, which is subject to a stockholder vote. </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;font-weight:bold;">About Centene Corporation</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;">Centene Corporation, a Fortune 100 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long-Term Services and Supports (LTSS), in addition to other state-sponsored programs, Medicare (including the Medicare prescription drug benefit commonly known as "Part D"), dual eligible programs and programs with the U.S. Department of Defense. Centene also provides healthcare services to groups and individuals delivered through commercial health plans. Centene operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, commercial programs, home-based primary care services, life and health management, vision benefits management, pharmacy benefits management, specialty pharmacy and telehealth services. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;">Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations websit</font><font style="font-family:inherit;font-size:10pt;">e, http://www.centene.com/investors. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;font-style:italic;">The company and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act (PSLRA) of 1995, including statements in this and other press releases, in presentations, filings with the&#160;Securities and Exchange Commission&#160;(SEC), reports to stockholders and in meetings with investors and analysts. In particular, the information provided in this press release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of&#160;Centene&#160;and certain plans and objectives of&#160;Centene&#160;with respect thereto, including but not limited to the expected benefits of the acquisition of&#160;Health Net, Inc.&#160;(Health Net) (Health Net Acquisition) and the acquisition of&#160;New York State Catholic Health Plan, Inc., d/b/a Fidelis Care New York (Fidelis Care) (Fidelis Care Acquisition). These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Without limiting the foregoing, forward-looking statements often use words such as "believe", "anticipate", "plan", "expect", "estimate", "intend", "seek", "target", "goal", "may", "will", "would", "could", "should", "can", "continue" and other similar words and expressions (and the negative thereof). We intend such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in PSLRA. A number of factors, variables or events could cause actual plans and results to differ materially from those expressed or implied in forward-looking statements. Such factors include, but are not limited to,&#160;Centene's&#160;ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder that may result from changing political conditions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting&#160;Centene's&#160;government businesses;&#160;Centene's&#160;ability to adequately price products on federally facilitated and state-based Health Insurance Marketplaces; tax matters; disasters or major epidemics; the outcome of legal and regulatory proceedings; changes in expected contract start dates; provider, state, federal and other contract changes and timing of regulatory approval of contracts; the expiration, suspension or termination of&#160;Centene's contracts with federal or state governments (including but not limited to&#160;Medicaid,&#160;Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of pending or future litigation or government investigations; challenges to&#160;Centene's&#160;contract awards; cyber-attacks or other privacy or data security incidents; the possibility that the expected synergies and value creation from acquired businesses, including, without limitation, the Health Net Acquisition and the Fidelis Care Acquisition, will not be realized, or will not be realized within the expected time period; the exertion of management's time and&#160;Centene's&#160;resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for the Health Net Acquisition or the Fidelis Care Acquisition; disruption caused by significant completed and pending acquisitions, including the Health Net Acquisition and the Fidelis Care Acquisition, making it more difficult to maintain business and operational relationships; the risk that unexpected costs will be incurred in connection with the completion and/or integration of acquisition transactions, including among others, the Health Net Acquisition and the Fidelis Care Acquisition; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses, including Health Net and Fidelis Care, will not be integrated successfully; the risk that, following the Fidelis Care Acquisition,&#160;Centene&#160;may not be able to effectively manage its expanded operations; restrictions and limitations in connection with&#160;Centene's indebtedness;&#160;Centene's&#160;ability to achieve improvement in the&#160;Centers for Medicare and Medicaid Services&#160;(CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable </font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;color:#333333;font-style:italic;">to&#160;Centene; inflation; foreign currency fluctuations; the stock split and the required stockholders approval to increase Centene's authorized common stock; and risks and uncertainties discussed in the reports that&#160;Centene&#160;has filed with the&#160;SEC. These forward-looking statements reflect&#160;Centene's&#160;current views with respect to future events and are based on numerous assumptions and assessments made by&#160;Centene&#160;in light of its experience and perception of historical trends, current conditions, business strategies, operating environments, future developments and other factors it believes appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in this press release could cause&#160;Centene's&#160;plans with respect to the Health Net Acquisition, the Fidelis Care Acquisition, actual results, performance or achievements, industry results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is currently believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct and persons reading this press release are therefore cautioned not to place undue reliance on these forward-looking statements which speak only as of the date of this press release.&#160;Centene&#160;does not assume any obligation to update the information contained in this press release (whether as a result of new information, future events or otherwise), except as required by applicable law. This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other risk factors that may affect&#160;Centene's&#160;business operations, financial condition and results of operations, in&#160;Centene's&#160;filings with the&#160;SEC, including the annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo1a07.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1a07.gif
M1TE&.#EA]P ] /<      (    "  ("     @(  @ " @+^_P,#<P*;*\
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M /__    __\ _P#______R'Y!       +     #W #T AP   (    "  ("
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MH/G*@@DXB<#" J8(-(<&Q%M*O N^?H8]\CA5:H(*-]!S3F>?65^^KQW(\+M
MY+0  O,H.#\PSM5GGSSW*'C?O,X?8+G'!L73GO+NM[S]S8]S90"@^0CX 0\<
MHG0<P G]4!"!:1R@ @+DW@ -*,'A4;!V>X!#$79!C18X81 ]H\@U5K E$-F
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M4"5MB")0LE21EXA5TB'!=YOU8 V34B[E(@$6< (5\#&XE"D>  CUL':>PG3
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ML1.7L%JL,C$F]<"5OAJ7,F@0Q, 3AM,X\O66T(JK;@,Z>C,!^LE>M<  )E5
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M%3T/%'T/&5W^#R;-T"Q]#XF<#*^\P;S0R<N,TLEP+^X@#"PM#(D\#]40TNH
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']NS' 0$ .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
